ALSO NOTED: FDA bans antibiotic in poultry; TargeGen targets lead drug; Advanced Life Sciences cuts IPO price; and much more...

> The FDA on Thursday banned the antibiotic Baytril in poultry, which belongs to the same drug class as the high-powered human drug Cipro, because of concerns that Baytril's use could lead to antibiotic-resistant infections in people. FDA chief Lester Crawford cited particular concerns about campylobacter bacteria, a growing source of serious illness in humans. It is the first time the FDA has withdrawn a veterinary drug on the basis of antibiotic resistance concerns. Story

> UK health experts warn that drug resistance isn't limited to bacteria. Report

> TargeGen designates topical macular degeneration treatment as its lead drug for clinical development. Release

>Abbot Labs licensee Advanced Life Sciences Holding cuts the price of its initial public offering, plans to issue more shares. Story

> Genzyme seeks US approval for enzyme-replacement treatment for Pompe disease. Release

> EU panel backs Amgen oral mucositis drug, Kepivance. Release

> Nicholas Piramal India launches Phase I trials of its cancer drug molecule, P276-00. Story

And Finally... Medical residents with access to free drug samples prescribed more heavily marketed drugs than residents without free samples, according to an American Journal of Medicine study. Report